20298 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin Lactones
BUTYLPHTHALIDE SOFT GEL CAPSULE AND ITS PREPARATION PROCEDURE
#1502Antioxidant and Fe2+ Chelating Properties of Herbal Extracts
#1503Measurement of soluble Tweak levels for evaluation of lupus patients
#1504Rapamycin Derivative or an Impdh Inhibitor For Treating Polycystic Kidney Disease
#1505Assay Method to Predict Sensitivity of Cancer Cell to Anticancer Drug
#1506VACUOLAR-TYPE (H+)-ATPase-INHIBITING COMPOUNDS, COMPOSITIONS, AND USES THEREOF
#1507PHARMACEUTICAL FORMULATION
#1508Composition for inhibiting nitric oxide and/or prostaglandin E2 synthesis and method for inhibiting inflammation
#1509Combination of Organic Compounds
#1510Use of phthalide derivatives
#1511Use of flibanserin in the treatment of obesity
#1512Method and composition of a carminative herb or natural supplement to decrease the adverse events of orlistat, an oral lipase inhibitor
#1513INHIBITORS OF THE CERAMIDE METABOLIC PATHWAY AS ADJUNCTS TO OPIATES FOR PAIN
#1514Use of specific cyklolignans
#1515Method for inhibition of viral infection
#1516Compounds and methods to enhance rAAV transduction
#1517Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury
#1518Dermally Applicable Formulations For Treating Skin Diseases in Animals
#1519Treatment of COPD, gastro-esophageal reflux disease (GERD), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibitors, LRA drugs, anti-H1 and/or anti-H2 drugs
#1520Pharmaceutical Multiparticulate Composit Ion Comprising Mycophenolic Acid or Myco Phenolate Sodium and Combination Compositions with Rapamycin
#1521Combinations Comprising a Protein Kinase Inhibitor Being a Pyrimidylaminobenzamide Compound and a Hsp90 Inhibitor Such as 17-Aag
#1522Combinations of Immunosupressive Agents for the Treatment or Prevention of Graft Rejections
#1523Angiogenesis inhibitors
#1524Cosmetic foundation
#1525Antiviral helioxanthin analogs
#1526PTX3-GENE EXPRESSION INHIBITOR
#1527Internal 1,15-lactones of fluprostenol and related prostaglandin F analogs and their use in the treatment of glaucoma and intraocular hypertension
#1528Use of specific cyklolignans
#1529TRPM2-specfic inhibitors
#1530Method of Treating Asthma, Allergic Rhinitis, and Skin Disorders
#1531ENHANCED OCULAR NEUROPROTECTION AND NEUROSTIMULATION
#1532Processes for preparation of crystalline mycophenolate sodium
#1533HMG CoA REDUCTASE MEDIATED MODULATION OF NEUROGENESIS
#1534ENHANCED RECOVERY FOLLOWING OCULAR SURGERY
#1535Trace elements
#1536Processes for preparation of crystalline mycophenolate sodium
#1537Topical and intravaginal microbicidal and antiparasitic compositions comprising quassinoids or quassinoid-containing plant extracts
#1538Internal 1,15-lactones of fluprostenol and related prostaglandin F analogs and their use in the treatment of glaucoma and intraocular hypertension
#1539Method and composition of a medicament to decrease the adverse events of Olistat, an oral lipase inhibitor
#1540Method and formulations to concurrently reduce fracture risk and insure appropriate fat-soluble vitamin supplementation when using Orlistat, an oral lipase inhibitor
#1541Method and composition of a carminative herb or natural supplement to decrease the adverse effects of orlistat, and oral lipase inhibitor
#1542Methods of stimulating cellular growth, synaptic remodelling and consolidation of long-term memory
#1543Anti-demodicosis agent
#1544COMBINATIONS COMPRISING COX-2 INHIBITORS AND ASPIRIN
#1545Protection From And Treatment Of Prion Protein Infection
#1546Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory
#1547Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
#1548Butylphtualide Soft Gel Capsule and Its Preperation Procedure
#1549Pharmacological treatment of cognitive impairment
#1550Genipin derivatives and uses thereof
#1551METHODS TO PREVENT AND TREAT DISEASES
#1552Methods for alzheimer's disease treatment and cognitive enhancement
#1553Treatment of depressive disorders
#1554Composition for Accelerating Calcium Absorption
#1555Pyrrolo[2,3-d]pyrimidine compounds
#1556Application of L-n-butylphthalide in preventing and treating dementia
#1557Agents for the treatment of viral infections
#1558Pharmaceutical compositions and methods for peptide treatment
#1559Method for treatment of diarrhea-predominant irritable bowel syndrome
#1560Method of inhibiting inflammatory pain
#1561Neobritannilactone B and acetyl neobritannilactone B
#1562Method for Treatment of Inflammatory Disorders Using Triptolide Compounds
#1563Formulations Of Low Dose Non-Steroidal Anti-Inflammatory Drugs And Beta-Cyclodextrin
#1564Disease modifying anti-arthritic activity of 2-methoxyestradiol
#1565Combination therapy for anthrax using antibiotics and protease inhibitors
#1566Methods of treating muscular wasting diseases using NF-κB activation inhibitors
#1567Reagents and methods for cancer treatment and prevention
#1568Pharmaceutical compositions
#1569Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
#1570Pharmaceutical composition
#1571Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
#1572DUAL-RELEASE COMPOSITIONS OF A CYCLOOXYGENASE-2 INHIBITOR
#1573Weight loss induced by reduction in neuropeptide level
#1574Treatment of diseases associated with the use of antibiotics
#1575Methods for inhibiting osteoclastogenesis
#1576Pharmaceutical formulation
#1577Concentricolide and its derivatives, process for preparing them, pharmaceutical composition comprising the same and its use
#1578Inhibitor of cancer bone metastasis
#1579Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same
#1580Therapeutic inhibitor of vascular smooth muscle cells
#1581METHOD OF USING HEPATIC PROGENITORS IN TREATING LIVER DYSFUNCTION
#1582Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections
#1583Method for inhibiting cancer development by fatty acid synthase inhibitors
#1584Soft capsule of butylphthalide and a process for preparing the same
#1585Therapeutic inhibitor of vascular smooth muscle cells
#1586Benzimidazole non-aqueous compositions
#1587Composition for preventing and treating hepatoma
#1588Compositions and Methods For Treating Inflammatory Disorders
#1589Compositions and methods for treatment and prevention of metabolic syndrome and its associated conditions with combinations of flavonoids, liminoids and tocotrienols
#1590Apparatus and method of wart treatment
#1591Inhibiting GS-FDH to modulate no bioactivity
#1592Combination of 2,3-dibenzylbutyrolactone and licochalcone-a
#1593Methods and compositions for controlling biofilm development
#1594Compositions and methods for modulating poly(ADP-ribose) polymerase activity
#1595Combination therapy for treating chronic inflammatory diseases
#1596In vitro and in vivo anti-inflammatory effects of a sesquiterpene lactone extract from chicory ( L.)
#1597Topical pharmaceutical composition for the treatment of inflammatory dermatoses
#1598Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer
#1599Cancer chemotherapy compositions comprising PI3K pathways modulators and triptolide
#1600Therapeutic agent
#1601Stimulation of CPT-1 as a means to reduce weight
#1602Anti cancer combinations comprising a cox-2 inhibitor
#1603Wound and skin care products
#1604Ocular administration of immunosuppressive agents
#1605Enhanced ocular neuroprotection and neurostimulation
#1606Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
#1607Compositions for the treatment of atopic dermatitis, skin allergic conditions and acne
#1608Combinations of immunosupressive agents for the treatment or prevention of graft rejections
#1609Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learning
#1610Ectoparasiticidal formulations of spinosyms and azole pesticides
#1611Anti-stress agent
#1612Pkc activation as a means for enhancing sappalpha secretion and improving cognition using bryostatin type compounds
#1613Migrastatin analogs and uses thereof
#1614Migrastatin analogs and uses thereof
#1615Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination with rapamycin
#1616Agents for treating neurodegenerative diseases
#1617Anorectic
#1618Enhanced ocular neuroprotection and neurostimulation
#1619Novel pharmaceutical granulate
#1620Therapeutic compositions and methods
#1621Enhanced recovery following ocular surgery
#1622Acyl homoserine lactones for inhibition of cell growth
#1623Compositions and methods involving MDA-7 for the treatment of cancer
#1624Remedy for diseases associated with immunoglobulin gene translocation
#1625Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease
#1626Method for enhancing leukocyte immune function
#1627Pharmaceutical composition combining tenatoprazole and an anti-inflamatory agent
#1628Methods and reagents for the treatment of inflammatory disorders
#1629Compositions and methods for the treatment of muscular dystrophy
#1630Treatment of inflammatory disorders
#1631Methods for treating brain swelling with a compound that blocks a non-selective cation channel
#1632Orlistat compositions
#1633Methods and compositions for the treatment of helicobacter pylori-associated diseases using endoperoxide bridge-containing compounds
#1634Method for the asymmetric synthesis of beta-lactone compounds
#1635Coated tablets
#1636Kavalactone product
#1637DNA damaging agents in combination with tyrosine kinase inhibitors
#1638Oral delivery of a botanical
#16397H-dibenzo[b,g][1,5]dioxocin-5-one derivatives and use thereof
#1640Crude extracts from
#1641Nanoparticulate lipase inhibitor formulations
#1642Pyrrolo[2,3-d]pyrimidine compounds
#1643Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
#1644Ocular solutions
#1645Ocular solutions
#1646Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
#1647Andrographolide derivatives to treat viral infections
#1648Palatable ductile chewable veterinary composition
#1649Cancer treatment with epothilones
#1650Biologically active macrolides, compositions, and uses thereof
#1651Formulation of a mixture of Free-B-Ring flavonoids and flavans as a therapeutic agent
#1652Dual controlled release dosage form
#1653Topical medicaments and methods for photodynamic treatment of disease
#1654Pharmaceutical formulation and a method of making same
#1655Method of treating high plasma cholesterol levels
#1656Compositions and therapeutic methods utilizing a combination of a 5-HT1F inhibitor and an NSAID
#1657Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an NSAID
#1658Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors
#1659Use of selective cyclooxygenase-2 inhibitors for the treatment of endometriosis
#1660Internal 1,15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension
#1661Modulators of FAAH
#1662Methods and compositions for the treatment of psychiatric disorders
#1663Triterpenoid derivatives
#1664Use of cyclolignans and new cyclolignans
#1665Pharmaceutical formulations of celcoxib
#1666Method of treating tuberculosis
#1667Novel podophyllotoxin compositions
#1668Genipin derivatives and uses thereof
#1669Methods of treating microbial infections in humans and animals
#1670Anti-obesity compositions
#1671Treatment of refractory cancers using NA+/K+ ATPase inhibitors
#1672Pharmaceutical compositions with improved dissolution
#1673Method of using adapalene in acne maintenance therapy
#1674Levamisole, avermectins or similar in pyrrolidone solvent
#1675TNF-alpha production inhibitor comprising kavalactone as an active ingredient
#1676Topical parasiticide formulations and methods of treatment
#1677Vaccine immunotherapy for immune suppressed patients
#1678Agents and methods for administration to the central nervous system
#1679Nanoparticles for targeting hepatoma cells
#1680Pharmaceutical composition and health food comprising extract of Phellinus sp. PL3 or phellinsin a isolated from the same as an effective component for prevention and treatment of cardiovascular disease
#1681Pharmaceutical compositions comprising a selective COX-2 inhibitor and a diuretic
#1682Metabolism-modulating agents and uses therefor
#1683Anthelmintic compositions
#1684Topical skin care composition
#1685Remedy for corneal ulcer
#1686Combinations of a vanilloid antagonist and an NSAID for the treatment of pain
#1687Compounds and methods to enhance rAAV transduction
#1688Treating prostate cancer with anti-ErbB2 antibodies
#1689Specific kinase inhibitors
#1690Crystalline mycophenolate sodium
#1691Processes for preparation of crystalline mycophenolate sodium
#1692GHB compositions
#1693Methods of treating obesity with combination therapeutics
#1694Drug delivery from embolic agents
#1695Combination of an hmg-coa reductase inhibitor and a nitrate ester
#1696Pharmaceutical compositions with improved dissolution
#1697Method of treating ischemia-reperfusion injury
#1698Inhibitor of anticancer drug side effect
#1699Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4
#1700Nonsteroidal antiinflammatory agents
#1701Method for inhibition of viral infection
#1702Anhydride modified cantharidin analogues useful in the treatment of cancer
#1703Methods for decreasing beta amyloid protein
#1704Drug or cosmetic
#1705Treatment method comprising administering feverfew to oral mucosal tissues in solid or semi-solid form
#1706Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor
#1707Topical pharmaceutical composition to treat hyperpigmentation of the skin
#1708Cancer chemotherapy
#1709Pyrrolo[2,3-D]pyrimidine compounds
#1710Vaginal health products
#1711Ginkgolides for inhibition of membrane expression of benzodiazepine receptors
#1712Combination of selected analgesics and COX-II inhibitors
#1713Combinations of immunosupressive agents for the treatment or prevention of graft rejections
#1714Use of targeted oxidative therapeutic formulation in treatment of type 2 diabetes
#1715Inflammatory eye disease
#1716HSP90-inhibiting zearalanol compounds and methods of producing and using same
#1717Mycophenolate mofetil in diabetic nephropathy
#1718Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug
#1719Anthelmintic composition
#1720Use of topoisomerase inhibitors and heat shock protein 90 inhibitors for use in chemotherapy
#1721Synthetic lactone formulations and method of use
#17222 Methoxy antimycin a derivatives and methods of use
#1723Combination of an agent that attenuates topoisomerase 1 activity and an agent that inhibits heat shock protein 90 for use in chemotherapy
#1724Pharmaceutical compositions and methods for peptide treatment
#1725Combination therapy comprising a Cox-2 inhibitor and an antineoplastic agent
#1726Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use
#1727Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
#1728Andrographolide and analogues as inhibitors of TNFα and IL-1β expression
#1729Combination therapies with epothilones and carboplatin
#1730Method and compositions for treatment of chronic neuropathic pain
#1731Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
#1732Antiparasitic composition
#1733Nerve growth factor activity potentiating agents
#1734Cytotoxin compound and method of isolation
#1735Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
#1736Combination of a Cox-2 inhibitor and a DNA topoisomerase I inhibitor for treatment of neoplasia
#1737Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
#1738Medicinal composition containing an HMG-CoA reductase inhibitor
#1739Ocular drug delivery
#1740Deuterated substituted dihydrofuranones and medicaments containing these compounds
#1741Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolferative diseases
#1742Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of central nervous system damage
#1743Statin-carboxyalkylether combinations
#1744Avermectin derivatives
#1745Inhibitors of proteasomal activity for stimulating hair growth
#1746Stimulation of cpt-1 as a means to reduce weight
#1747Selective preventing and therapeutic agents for progressive lesion after organic damage
#1748Use of parthenolide to inhibit cancer
#1749Novel medical combination treatment of obesity involving 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
#1750Method for isolating terpene trilactones (ginkgolides, bilobadide) from leaves and pharmaceutical powders of ginkgo biloba
#1751Orlistat compositions
#1752Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor
#1753Biocompatible, biostable coating of medical surfaces
#1754Polyether brevetoxin derivatives as a treatment for neurotoxic shellfish poisoning and ciguatera fish poisoning
#1755Decahydronaphtho[2,3-c]furan derivatives
#1756Urea derivatives
#1757Methods for the prevention or treament of bacterial and fungal infections
#1758Treatment of circadian rhythm disorders with NPY Y5 receptor antagonist
#1759DAPD combination therapy with inosine monophosphate dehydrogenase inhibitor
#1760Medical uses of intercellular communication facilitating compounds
#1761Antitumor agent containing lactic acid oligomer mixture
#1762Methods of treating lower urinary tract disorders using losigamone
#1763Stimulation of CPT-1 as a means to reduce weight
#1764Lipase inhibiting composition
#1765Analgesic and anti-inflammatory compositions containing Cox-2-inhibitors
#1766Method and formulation for treating vascular disease
#1767Transdermal and topical administration of drugs using basic permeation enhancers
#1768Methods for Alzheimer's disease treatment and cognitive enhance
#1769Ocular solutions
#1770Ocular solutions
#1771Inhibition of two-component signal transduction systems
#1772Pharmaceutical composition
#1773Method for prevention or treatment of periodontal diseases and composition for an oral cavity
#1774Process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2-enzyme inhibitors
#1775Benzoic acid derivatives and uses thereof
#1776Upregulation of type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors
#1777Methods for Alzheimer's Disease treatment and cognitive enhancement
#1778Compositions and methods for the treatment of depression and other affective disorders
#1779Oral pharmaceutical composition containing a combination pparalpha and a hmg-coa reductase inhibitor
#1780Antitumor combined therapy
#1781Methods for treating inflammation and inflammation-associated diseases with a statin and ether
#1782Zonisamide use in eating disorders
#1783Pharmaceutical compositions comprising alkanoyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism
#1784Pharmaceutical compositions with improved dissolution
#1785Inhibitors of proteasomal activity for stimulating hair growth
#1786Wart treatment
#1787Transgenic mice expressing inducible human p25
#1788Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia
#1789Endostatin-like angiogenesis inhibition
#1790Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol
#1791Method of treating tuberculosis
#1792Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
#1793Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist
#1794Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia
#1795Composition for improving respiratory health of companion animals
#17962-benzo-[3,4-b] quinolino-{b,g]indeno [1′,2′:3,4] fluoreno-[1,2-d] Oxonine-5,11,16,21-tetraone as an antimicrobial compound
#1797Compositions and methods for immune health
#17989-flouro-dibenzo[B,G]indeno[1′, 2′:3,4]fluoreno-[1,2-D]oxonine-5, 11, 16,21-tetraone as an antimicrobial agent
#1799Treatment of proteoglycan accumulation diseases
#1800Natural and synthetic andrographolides compounds for the treatment of skeletal muscular dystrophies